9
Participants
Start Date
March 16, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
SGLT2 inhibitor
SGTL2i (15 mg) once daily
Controlled, Adaptive Study Diet
An adaptive study diet combined with SGLT2i, which consists of four sequential, 7-day long phases in which dietary carbohydrates are gradually reduced (50% carbs, 30% carbs, 20% carbs, and 10% carbs) based on safety and tolerability to achieve moderate ketosis. All diet phases are isocaloric. All meals are provided on an inpatient unit.
AdventHealth Translational Research Institute, Orlando
AdventHealth Translational Research Institute
OTHER